Axogen, Inc. Overview
Pro stress-test →Axogen is the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company processes human tissue and develops a comprehensive portfolio of surgical solutions including grafts, connectors, and protective membranes for surgeons treating peripheral nerve injuries. The platform serves various applications and surgical specialties, including traumatic injuries, oral and maxillofacial surgery, breast reconstruction, and the surgical treatment of pain.
Strategic Profile
Pro stress-test →Axogen employs a direct sales model supported by a dedicated sales force that engages with healthcare professionals, maintaining strong relationships with surgeons to ensure proper utilization of products. Innovation is at the core of the company's strategy, with heavy investments in R&D to develop new technologies and improve existing products, maintaining a competitive edge while addressing unmet medical needs in the nerve repair market.
Competitive Landscape
Pro stress-test →Axogen competes against larger, diversified medical device companies including Stryker, which has broad orthopedic and spine surgery offerings; Medtronic, a global medical technology leader with extensive product range; and Integra LifeSciences, which focuses on regenerative medicine and soft tissue reconstruction.
Industry Context
Axogen, Inc. operates in Medical Devices - Surgical Solutions & Peripheral Nerve Repair.
Key facts
Founded: 2002 · Headquarters: Alachua, FL · Revenue: $60.1M (Q3 2025)